Back

Left ventricular kinetic energy across heart failure subgroups and subclinical diastolic dysfunction

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Clinical implications of new methods to assess cardiac function Flow Imaging ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Anders Nelsson

Lund University, Lund (Sweden)

5 More presentations in this session

Presentation thumbnail
Prognostic utility of left ventricular global longitudinal strain in patients with systemic amyloidosis.
Doctor K. Bhatia (New York, US)
Abstract Slides Video
Presentation thumbnail
Right ventricular function and outcome in patients undergoing transcatheter mitral valve repair
Doctor M. Koschutnik (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Left atrial strain at CMR is a strong independent prognostic predictor in DCM, superior to LV-GLS, LVEF and LAVI, and incremental to LGE
Miss A. Raafs (Eindhoven, NL)
Abstract Slides Video
Presentation thumbnail
Regional strain score as prognostic marker of cardiovascular events. from the multi-ethnic study of atherosclerosis (MESA)
Doctor T. Pezel (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Cardiovascular structure and function assessed by MRI in healthy South Asians compared to White Europeans: a UK Biobank study
Mrs K. Parke (Leicester, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical implications of new methods to assess cardiac function

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Diastolic function in patients with preserved left ventricle ejection fraction: prognostic value and added role of left atrial strain
thumbnail
Congress Presentation
Peak atrial longitudinal strain to replace atrial volume in diastolic function grading: associations with long-term outcomes in a community-based sample with normal left ventricular ejection fraction
thumbnail
Congress Presentation
Threshold values for diastolic dysfunction parameters indicative of increased mortality risk in a real-world patient cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources